Lantern Pharma Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of LP-184 in Patients With Advanced Solid Tumors (NCT05933265) | Lantern Pharma Inc. | 2023-06-09 |
| A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma (NCT05456256) | Lantern Pharma Inc. | 2023-03-01 |
| Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors (NCT06132503) | Lantern Pharma Inc. | 2023-01-03 |
Track Lantern Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.